Spontaneous cholesteatoma of the external auditory canal (EAC) is an uncommon condition that is diffi cult to diagnose. In a patient with such a possibility, serious clinical investigation along with radiologic and histologic exploration should be performed early on because a delay in treatment can lead to severe complications. Given the rarity of EAC cholesteatoma, no therapeutic consensus has emerged. The type of management depends on the extensiveness of invasion and bone erosion and the status of the neighboring structures. The primary therapeutic objectives are to eradicate the cholesteatoma and then to fi ll in the residual cavity, which in our opinion can be best accomplished with a muscle fl ap and EAC reconstruction. Postoperative follow-up should be carried out to look for infections, stenosis, and recurrence. We report a new case of spontaneous EAC cholesteatoma, and we review its diagnostic and therapeutic challenges.
Introduction
Cholesteatoma of the external auditory canal (EAC) is a rare condition; its estimated incidence is 1.2 per 1,000 new otologic patients. 1 Early reports of EAC cholesteatoma were published in 1850 by Toynbee and in 1893 by Scholefi eld. 2 Primary (spontaneous) EAC cholesteatoma is a particular entity that has been described as an apparently idiopathic condition with an unclear pathogenic mechanism. Early diagnosis of this entity is far from easy.
Delayed diagnosis could lead to serious complications, such as facial palsy and intracranial extension.
In this article, we report a case of spontaneous EAC cholesteatoma in association with facial paresis. We also describe the clinical aspects of EAC cholesteatoma and the diagnostic diffi culties, potential complications, and therapeutic approaches.
Case report
A 38-year-old woman presented with a 7-year history of chronic left ear pain, intermittent otorrhea, and hearing loss. She had been treated for external otitis for 3 months without resolution. She had no history of bronchopulmonary disease or sinusitis.
Upon examination, the left EAC appeared to be fi lled with a voluminous polyp. In addition, the examination revealed a left peripheral facial paresis that had gone unnoticed by the patient. Pure-tone audiometry revealed a 40-dB conductive hearing loss in the left ear. In all aspects, the right ear was normal. Computed tomography (CT) of the left temporal bone detected a soft-tissue mass and extensive osteolysis of the tympanic bone that extended to the mastoid tip (fi gure 1). The middle ear was well aerated, and the ossicular chain was intact.
The patient was taken for surgical exploration under general anesthesia. Removal of the polyp in the ear canal revealed the presence of a huge (3 cm in diameter) cholesteatoma sac that had eroded the inferior and posterior EAC and extended to the mastoid tip (fi gure 2, A). The sac was adjacent to the annulus. The tympanic membrane was intact. The middle ear was clean and free of cholesteatoma and infection. The entire cholesteatoma was removed. Meanwhile, a 5-mm portion of the vertical segment of the facial nerve was found to be dehiscent (fi gure 2, B). After fi lling the cavity that was created in the mastoid with a muscle fl ap, we performed a canaloplasty with a temporalis fascia graft.
Systemic antibiotics were administered for 2 weeks postoperatively. The patient's facial paresis resolved within 10 days, and complete healing was achieved 4 weeks later. The EAC was smooth and without a cavity, and the eardrum and EAC were normal 18 months after the operation. Findings on pure-tone audiometry returned to within a normal range, and there was no difference in hearing between the two ears.
Discussion
Cholesteatoma occurs mainly in the middle ear and the mastoid cavity. Only in rare cases has it been found in the EAC. 2 Although its precise etiology is still unknown, the basic pathogenesis is presumed to involve a narrowing of the EAC 3 and faulty epithelial migration. 4 Local accumulation of squamous epithelium in the medial portion of the EAC could lead to an epithelial cyst formation deep to the skin that could evolve into a cholesteatoma. 5, 6 It is believed that congenital EAC cholesteatoma may occur as the result of an arrest in the development of the EAC and the subsequent development of isolated nests of epithelial cells. 7 Recently, Dubach and Häusler suggested that risk factors for the development of spontaneous EAC cholesteatoma include disruption of the local microcirculation by smoking, diabetes mellitus, or microtrauma from the use of cotton swabs. 8 These factors were not signifi cantly demonstrated in our case.
Moreover, some immunohistochemical investigations have provided valuable basic information on the etiology of this condition. Researchers have reported that the development of EAC cholesteatomas is accompanied by an increase in various growth factors, 9 including endothelial growth factor (which might indicate tissue hypoxia 10 ) and hepatocyte growth factor (which is involved in epithelial cell apoptosis and debris formation 11 ).
Classifi cation. Several classifi cations of EAC cholesteatoma have been proposed. 12, 13 Tos identifi ed three types: primary, secondary, and cholesteatoma associated Figure 2 . A: After removal of the canal polyp, the large cholesteatoma is seen extending to the mastoid tip. B: With the entire cholesteatoma removed, a 5-mm portion of the vertical segment of the facial nerve is found to be dehiscent. The tympanic membrane is intact.
Figure 1. Coronal CT of the left temporal bone shows the soft-tissue mass fi lling the EAC, erosion of the subjacent bone, and medial bowing of the tympanic membrane.
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with congenital atresia of the ear canal. 12 Secondary EAC cholesteatoma is related to a variety of conditions, mainly postoperative; other factors associated with secondary EAC cholesteatomas include recurrent infl ammation, postinfl ammatory and post-traumatic canal stenosis, and atresia. 14 Naim et al 13 proposed a scheme that classifi es EAC cholesteatoma according to its different histopathologic characteristics and clinical stages: The EAC cholesteatoma in our patient was classifi ed as a primary one according to the Tos classifi cation system, 12 and as stage IV, subclass M and F, according to the classifi cation system of Naim et al. 13 Few studies have focused on the prevalence or incidence of primary EAC cholesteatoma, but according to Owen et al, the primary type is the most common form, with a reported prevalence ranging from 41 to 62% and an annual incidence estimated at 0.15 cases per 100,000 population. 14 in the elderly. 2, 14 Males appear to be just slightly more vulnerable than females (ratio: 1.1:1). 14 Presentation. The most common complaints reported in the literature are otalgia (8 to 100% of cases) and purulent otorrhea (4 to 100%). 14 Other manifestations include occlusion (16%), hearing loss (12 to 25%), fullness (8 to 38%), itching (8 to 20%), and otorrhea (4%). 14 When pain occurs, it is primarily caused by the invasion of squamous tissue into the adjacent bony canal with periostitis. 14 The presence of hearing loss is inconsistent; it is usually seen when the cholesteatoma occludes the ear canal, 1 unless the cholesteatoma has invaded the middle ear. 2 When hearing loss is sensorineural, it may be the result of a long-standing infectious process and the passage of toxic substances through the round window membrane. 3 The tympanic membrane is usually normal. 15 Not all cases of EAC cholesteatoma are symptomatic, and this condition may progress silently as an insidious, destructive entity. Asymptomatic forms were found in 31% of cases by Vrabec and Chaljub 5 and in 24% of cases by Owen et al. 14 Diagnosis. After a studious clinical inquiry has been performed, CT is usually helpful whenever a defective bony canal is found to harbor a cavity that could not be assessed clinically. In fact, imaging studies often reveal a more extensive mass than what would be expected clinically. CT is highly recommended to appreciate the true extent of the disease, to identify the subtle or insidious involvement of other structures, and to develop the therapeutic plan. 16, 17 Even with CT, the diagnosis of EAC cholesteatoma is far from easy. Several infl ammatory, infective, and neoplastic processes of the EAC can clinically mimic EAC cholesteatoma; among them are keratosis obturans, postinfl ammatory medial canal fi brosis, necrotizing external otitis, and squamous cell carcinoma. 16 Keratosis obturans is the most closely related condition and the one that is most diffi cult to distinguish from EAC cholesteatoma. In fact, the terms EAC cholesteatoma and keratosis obturans were once used interchangeably. However, the treatment strategies are different, and therefore making the distinction between the two is crucial. Piepergerdes et al were the fi rst to make the distinction, 18 and later, several other distinguishing factors were identifi ed (table 1). Persaud et al reviewed the literature to fi nd even clearer distinctions, and they concluded that there were still no reliable consistent symptoms or clinical signs that could differentiate the two conditions. 15 They found that the most use-ful fi nding for confi rming an EAC cholesteatoma was focal osteonecrosis or sequestration of bone and focal overlying epithelial loss. But even so, differentiation remains diffi cult. Keratosis obturans may be associated with fallopian canal or lateral sinus erosion, horizontal semicircular canal fi stula, extensive dehiscence of the tegmen tympani, and facial palsy. 19 Delays in diagnosis and management are associated with a high rate of complications. Delays increase the risk of cholesteatoma extension to neighboring structures, which may render therapy less effective and worsen the prognosis. Because EAC cholesteatoma is such a rare condition, little attention has been paid to its complications (table 2), and invasion of adjacent structures has rarely been described. When a cholesteatoma spreads into the mastoid, it may erode the facial canal, the sigmoid sinus, and the semicircular canal. Cholesteatoma invasion of the middle ear can lead to disruption of the ossicular chain, dehiscence of the tegmen tympani and dura, and denudement of the jugular bulb. When the anterior canal wall is involved, the temporomandibular joint capsule could become exposed and eroded. Other reported complications have included parotid gland fi stula and cerebellar abscess.
Treatment. The management of EAC cholesteatoma varies according to its extent and the involvement of cir-cumjacent structures. For cases in which a small lesion's complete extension into the bone can be visualized, most authors recommend conservative medical therapy with frequent cleaning and debridement of keratin debris and sequestered bone under local anesthesia. 5 However, some authors have found that even small lesions may represent osteitis resistant to conservative treatment and thus require a more aggressive strategy. 20 According to Naim et al, the therapy of choice for stage II and III EAC cholesteatomas is surgical removal via an endaural approach with local anesthesia. 13 For lesions that require more extensive surgery, they recommend a postauricular incision and a transcanal approach for more adequate debridement and canaloplasty.
We join other authors in thinking that medical approaches are suffi cient for superfi cial and controllable EAC cholesteatomas. But if simple measures prove to be inadequate for controlling pain and discharge, a canaloplasty via an endaural or postauricular approach should be undertaken.
Surgery is necessary for a patient who complains of chronic pain, frequent infection, a substantial conductive hearing impairment, facial palsy, chronic dizziness, involvement of the hypotympanum or the mastoid, and/or progression during follow-up. Surgery is recommended in patients who are predisposed to necrotizing external otitis, such as those with diabetes mellitus or immunosuppression. 21 The site of bone destruction also determines the choice of surgical procedure. When the middle ear is invaded, almost all authors recommend a canal-walldown mastoidectomy for better cholesteatoma control and easier follow-up. 21 When the mastoid is invaded without middle ear involvement, the dehiscence of the facial nerve with or without paresis could occur, and nerve injuries could happen during surgery. Canal wall reconstruction is usually performed. 2 Some surgeons opt for a modifi ed radical mastoidectomy and wide meatoplasty to achieve good control of the cavity during the postoperative period. 21 For patients with a large cholesteatoma and facial nerve dehiscence, some surgeons choose a canalwall-down mastoidectomy and conchomeatoplasty with preservation of the tympanic membrane and the ossicles. 7 A canal-wall-down mastoidectomy may also be reasonable in pediatric cases, where cholesteatoma is known to be more aggressive and highly recurrent. 2 During surgery, all affected skin should be removed, the surrounding healthy skin edges should be left, and the meatal skin should be raised. The bone should be drilled off and saucerized with a diamond bur to remove any residual disease and to achieve a smoother area. Several substances can be used to fi ll in the canal defect, including skin, a soft-tissue graft, cartilage, and temporalis fascia. To rebuild the ear canal, Owen et al reported using fascia grafts in superfi cial cases and cartilage in extensive cases. 14 split-thickness skin grafting to cover the canal defect. 20 Anthony and Anthony proposed the use of fascia when at least 35% of the epithelial lining is affected. 1 In one case of EAC cholesteatoma with a facial nerve exposure, following the dissection of the epithelial lesion and after controlling the total cholesteatoma excision, they used a soft-tissue graft to fi ll in the defect and the fascia to direct epithelial coverage over the free graft. In the case of large defects, Tos recommended the obliteration of the defect with an inferiorly based subcutis muscle periosteal fl ap harvested along the posterior edge of the incision. 12 In cases of otogenic intracranial complications, surgical treatment should be considered after any neurologic conditions have been stabilized. Our patient had a huge bone defect, mastoid involvement, and facial nerve exposure without middle ear invasion, and therefore we chose the option recommended by Anthony and Anthony 1 and performed the posterior exploration (for greater exposure of all anatomic structures) and canaloplasty with a temporalis fascia graft after total cholesteatoma excision. We also fi lled the mastoid cavity with a muscle fl ap.
Garin et al recommend
We believe that canal-wall-down mastoidectomy should not be the treatment of choice for EAC cholesteatomas, even for large ones that extend to the mastoid and involve the facial nerve. Canal wall reconstruction is preferred because it requires little postoperative care and restoration of anatomic structures.
In patients with a history of respiratory pathology and when the distinction between EAC cholesteatoma and keratosis obturans is unclear, surgery is usually associ-ated with a delay in healing. The use of cartilage grafts or synthetic material for wall reconstruction should be avoided. Instead, the placement of a muscle fl ap roofed by fascia to fi ll in the bone defect and to rebuild the auditory canal seems to be the most stable means of achieving a durable auditory canal reconstruction.
Postoperative follow-up should be carried out to look for infections, stenosis, and recurrence. Jahnke and Lieberum reported that once the atresia of the EAC is complete, EAC cholesteatoma can recur. 22 Our patient was free of complications 18 months after surgery.
